[go: up one dir, main page]

KR810001047B1 - Method for preparing cyclic acetal derivative of sterylglucoside - Google Patents

Method for preparing cyclic acetal derivative of sterylglucoside Download PDF

Info

Publication number
KR810001047B1
KR810001047B1 KR7701265A KR770001265A KR810001047B1 KR 810001047 B1 KR810001047 B1 KR 810001047B1 KR 7701265 A KR7701265 A KR 7701265A KR 770001265 A KR770001265 A KR 770001265A KR 810001047 B1 KR810001047 B1 KR 810001047B1
Authority
KR
South Korea
Prior art keywords
group
general formula
sterylglucoside
glucopyranoside
cyclic acetal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR7701265A
Other languages
Korean (ko)
Inventor
무라이히로무
기다구찌고오지
노무라다다도시
Original Assignee
모리시다히로시
닛뽄신야구가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 모리시다히로시, 닛뽄신야구가부시기가이샤 filed Critical 모리시다히로시
Priority to KR7701265A priority Critical patent/KR810001047B1/en
Application granted granted Critical
Publication of KR810001047B1 publication Critical patent/KR810001047B1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04Cyclic acetals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Steroid Compounds (AREA)

Abstract

내용 없음.No content.

Description

스테릴글루코사이드의 환상아세탈 유도체의 제조방법Method for preparing cyclic acetal derivative of sterylglucoside

본 발명은 다음의 일반식(I)The present invention is the following general formula (I)

Figure kpo00001
Figure kpo00001

(식중 R은

Figure kpo00002
-시토스테릴기, 캄페스테릴기, 스티그마스테릴기 혹은 이들의 혼합물을 표시하거나, 또는 코레스테릴기를 표시한다.(Where R is
Figure kpo00002
-Represent a cytosteryl group, a camphorsteryl group, a stigmasteryl group or a mixture thereof, or a cholesteryl group.

R1는 H 또는 메틸기를 표시한다)으로 표시되는 2,3-옥시드 알킬리덴-4,6-알킬리덴-

Figure kpo00003
-D-글루코피라노시드 유도체의 제조방법에 관한 것이다. 본 화합물은 문헌에 미재인 신규물질로서, 우수한 혈관보강작용, 지혈작용, 항염증작용을 나타내고, 독성도 또 지극히 약하여 의약품으로서 유용하다. 본 발명의 화합물(I)은 여러가지 방법으로 합성할 수 있으나 특히 다음 방법이 바람직하다.R 1 represents H or a methyl group), 2,3-oxide alkylidene-4,6-alkylidene-
Figure kpo00003
A method for producing a -D-glucopyranoside derivative. This compound is a novel substance which is unknown in the literature, and has excellent vascular reinforcement, hemostatic action, and anti-inflammatory action, and its toxicity is extremely weak, so it is useful as a medicine. The compound (I) of the present invention can be synthesized by various methods, but the following method is particularly preferable.

즉 다음의 일반식(II)That is, the following general formula (II)

Figure kpo00004
Figure kpo00004

(식중 R은 상기와 같음)으로 표시되는 화합물로서 일반식(Ⅱ)(Wherein R is as defined above) as a compound represented by the general formula (II)

(R1CHO)n (Ⅱ)(R 1 CHO) n (II)

(식중 R1는 H 또는 메틸기를 표시하고, n은 3이상의 정수를 표시한다)으로 표시되는 파라포름알데히드, 파라알데히드등의 알데히드류를 산촉매의 존재하에서 반응시켜서 목적으로 하는 (I)은 합성시킨다.The target (I) is synthesized by reacting aldehydes such as paraformaldehyde and paraaldehyde in which R 1 represents H or a methyl group and n represents an integer of 3 or more in the presence of an acid catalyst. .

이 방법에 있어서 반응에 사용하는 과잉의 알데히드류 그 자체가 용매로 되는 경우도 있으나 필요하면 벤젠과 같은 유기용매를 첨가하여 행할수도 있다. 산촉매로서는 통상황산이 사용된다. 필요하면 탈수제를 첨가하여도 좋다.In this method, the excess aldehydes used in the reaction may be used as a solvent, but if necessary, it may be performed by adding an organic solvent such as benzene. Sulfuric acid is usually used as the acid catalyst. If necessary, a dehydrating agent may be added.

다음에 실시예로 상세히 설명하지만 본 발명은 이들 실시예만으로 한정되는 것은 아니다.The present invention will be described in detail with reference to the following Examples, but the present invention is not limited to these Examples.

[실시예 1]Example 1

스테릴-2,3-옥시도에틸리덴-4,6-에틸리덴-

Figure kpo00005
-D-글루코피라노시드, 스테릴-
Figure kpo00006
-D-글루코피라노시드(대두레시틴으로부터 추출제조한 스테릴-
Figure kpo00007
-D-글루코피라노시드로서, 그 스테롤의 조정은
Figure kpo00008
-시토스테롤 60%, 스티그마스테롤 20%, 캄페스테롤 20%이다) 10.0g을 300㎖의 프라스코에 넣어서 파라알데히드 100㎖를 첨가하여 현탁액으로 한다. 농황산 한 방울을 첨가하여 실온으로 24시간 교반한다. 벤젠 200㎖를 첨가하고 이어서 무수 탄산칼륨 10.0g을 첨가하고 실온으로 3시간 교반한후 여과한다. 감압하에서 벤젠 및 과잉된 파라알데히드를 유거한다. 잔류물에 에탄올을 첨가하면 결정화된다.Steryl-2,3-oxidoethylidene-4,6-ethylidene-
Figure kpo00005
D-glucopyranoside, sterilyl
Figure kpo00006
-D-glucopyranoside (steryl- extracted from soy lecithin)
Figure kpo00007
As -D-glucopyranoside, the sterol adjustment is
Figure kpo00008
10.0 g of 60% cytosterol, 20% stigmasterol, and 20% camphorol) is added to 300 ml of fresco and 100 ml of paraaldehyde is added to give a suspension. Add one drop of concentrated sulfuric acid and stir to room temperature for 24 hours. 200 ml of benzene is added, followed by 10.0 g of anhydrous potassium carbonate, which is stirred for 3 hours at room temperature and then filtered. Benzene and excess paraaldehyde are distilled off under reduced pressure. The addition of ethanol to the residue crystallizes.

에탄올에서 재결정한바 융점 184-186℃의 목적한 화합물의 무색판상 결정으로서 7.5g 얻어졌다(수율 64.4%)When recrystallized from ethanol, 7.5g of colorless crystals of the desired compound having a melting point of 184-186 占 폚 were obtained (yield 64.4%).

원소분석치 C41H68O7로서Elemental Analysis C 41 H 68 O 7 As

계산치 C : 73.17 H : 10.19Calculated C: 73.17 H: 10.19

실측치 C : 72.90 H : 10.10Found C: 72.90 H: 10.10

Figure kpo00009
Figure kpo00009

MS m/e 672, 670,658(M+)MS m / e 672, 670,658 (M + )

[실시예 2]Example 2

코레스테릴-2,3-옥시드에틸리덴-4,6-에틸리덴-

Figure kpo00010
-D-글루코피라노시드Coresteryl-2,3-oxideethylidene-4,6-ethylidene-
Figure kpo00010
-D-glucopyranoside

코레스테릴-

Figure kpo00011
-D-글루코피라노시드 4.0g을 200㎖의 나스콜에 넣어, 파라알데히드 50㎖로 현탁시키고, 농황산 한 방울을 첨가하여 실온으로 24시감 교반한다. 이어서 실시예 1의 경우와 같이 후처리를 하고 조제의 결정 4.8g을 얻은다. 이것을 에탄올에서 재결정한바 융점 177-178℃의 목적한 화합물의 3.1g이 무색침전상결정으로서 얻어졌다(수율 66.0%).Coresteryl
Figure kpo00011
4.0 g of -D-glucopyranoside was added to 200 ml of nascol, suspended with 50 ml of paraaldehyde, and a drop of concentrated sulfuric acid was added and stirred for 24 hours at room temperature. Subsequently, the same treatment as in Example 1 was carried out to obtain 4.8 g of the prepared crystal. When recrystallized from ethanol, 3.1 g of the target compound having a melting point of 177 to 178 ° C was obtained as colorless precipitated phase crystals (yield 66.0%).

원소분석치 C39H64O7로서Elemental Analysis C 39 H 64 O 7 As

계산치 C : 72.63 H : 10.00Calculation C: 72.63 H: 10.00

실측치 C : 72.53 H : 10.17Found C: 72.53 H: 10.17

Figure kpo00012
Figure kpo00012

[실시예 3]Example 3

Figure kpo00013
-시토스테릴-2,3-옥시드에틸리덴-4,6-
Figure kpo00014
-D-에릴리덴 글루코피라노시드
Figure kpo00013
-Cytosteryl-2,3-oxideethylidene-4,6-
Figure kpo00014
-D-Elylidene glucopyranoside

Figure kpo00015
-시토스테릴-
Figure kpo00016
-D-글루코피라노시드 3.0g을 200㎖의 프라스코에 넣어서, 파라알데히드 50㎖로 현탁시키고, 농황산 한 방울을 첨가하여 실온으로 12시감 교반한다. 이어서 실시예 1의 경우와 같이 후처리를 하고, 조결정 3.0g을 얻는다. 이것을 에탄올에서 재결정한바 융점 184~186℃의 목적한 화합물 2.6g이 무색침상 결정으로 얻어졌다(수율 74.3%).
Figure kpo00015
-Sitosteryl-
Figure kpo00016
3.0 g of -D-glucopyranoside was placed in 200 ml of fresco, suspended with 50 ml of paraaldehyde, and a drop of concentrated sulfuric acid was added and stirred at room temperature for 12 hours. Subsequently, post-treatment is performed as in the case of Example 1 to obtain 3.0 g of crude crystals. The crystals were recrystallized from ethanol to give 2.6 g of the target compound having a melting point of 184 to 186 캜 as colorless needles (yield 74.3%).

원소분석치 C41H68O7로서Elemental Analysis C 41 H 68 O 7 As

계산치 C : 73.17 H : 10.19Calculated C: 73.17 H: 10.19

실측치 C : 73.04 H : 10.16Found C: 73.04 H: 10.16

Figure kpo00017
Figure kpo00017

[실시예 4]Example 4

스테릴-2,3-옥시드메틸리덴-4,6-메틸리덴-

Figure kpo00018
-D-글루코피라노시드. 스테릴-
Figure kpo00019
-D-글루코시드(실시예 1의 경우와 같음) 10.0g을 300㎖의 프라스코에 넣어서, 파라포름 알데히드 10.0g과 벤젠 200㎖를 첨가하여 서현탁액으로 한다. 농황산 한 방울을 첨가하여 실온으로 24시간 교반한다. 그후 유거관을 붙여서 천천히 가온한다. 벤젠 유거에 따라서 반응이 진행된다. 균일한 용액으로 되었을 때 가열을 정지하고, 냉각시킨후 무수탄산칼륨 3.0g을 첨가하고 30분간 교반한다. 여과 후 감압으로 농축 건조시킨다. 벤젠에 용해시키고 칼람클로마토그래피(와코(和光)겔 C-200로 분리 정제한다. (벤젠/에테르 4 : 1 혼액으로 용출). 얻어진 미황색 분말을 에탄올에서 재결정하여 융점 160~162℃의 목적한 화합물 4.8g이 무색침상 결정으로서 얻어졌다(수율 43.9%)Steyl-2,3-oxidemethylidene-4,6-methylidene-
Figure kpo00018
-D-glucopyranoside. Steril
Figure kpo00019
10.0 g of -D-glucoside (as in Example 1) is placed in 300 ml of fresco, and 10.0 g of paraformaldehyde and 200 ml of benzene are added to prepare a suspension. Add one drop of concentrated sulfuric acid and stir to room temperature for 24 hours. After that, attach the canister and warm it up slowly. The reaction proceeds with benzene distillation. When it became a uniform solution, heating was stopped, and after cooling, 3.0 g of anhydrous potassium carbonate was added and stirred for 30 minutes. After filtration, concentrated to dryness under reduced pressure. It is dissolved in benzene and separated and purified by column chromatography (Wako gel C-200., Eluted with benzene / ether 4: 1 mixture). 4.8 g of compound was obtained as colorless needles (yield 43.9%)

원소분석치 C38H62O7로서Elemental Analysis As C 38 H 62 O 7

계산치 C : 72.34 H : 9.91Calculated C: 72.34 H: 9.91

실측치 C : 72.21 H : 10.02Found C: 72.21 H: 10.02

Figure kpo00020
Figure kpo00020

Claims (1)

다음 일반식(II)로 표시되는 화합물과 다음 일반식(III)으로 표시되는 파라포름알데히드, 파라알데히드등의 알데히드류를 산촉매의 존재하에서 반응시켜 다음 일반식(I)로 표시되는 4,6-옥시드알킬리덴-4,6-알킬리덴-
Figure kpo00021
-D-글루코피라노시드 유도체를 제조하는 방법
The compound represented by the following general formula (II) and the aldehydes such as paraformaldehyde and paraaldehyde represented by the following general formula (III) are reacted in the presence of an acid catalyst, and 4,6- represented by the following general formula (I) Oxidealkylidene-4,6-alkylidene-
Figure kpo00021
Method for preparing a -D-glucopyranoside derivative
Figure kpo00022
Figure kpo00022
일반식(III)General formula (III) (R1CHO)n (III)(R 1 CHO) n (III) 상기식에서In the above formula R은
Figure kpo00023
-시토스테릴기, 캄페스테릴기, 스티그마스테릴기 혹은 이들의 혼합물을 나타내던가 또는 코레스테릴기를 나타내며, R1은 H 또는 메틸기를 나타내고, n은 3이상의 정수를 나타낸다.
R is
Figure kpo00023
-Represent a cytosteryl group, camphorsteryl group, stigmasteryl group or a mixture thereof or a cholesteryl group, R 1 represents H or a methyl group and n represents an integer of 3 or more.
KR7701265A 1977-05-28 1977-05-28 Method for preparing cyclic acetal derivative of sterylglucoside Expired KR810001047B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR7701265A KR810001047B1 (en) 1977-05-28 1977-05-28 Method for preparing cyclic acetal derivative of sterylglucoside

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR7701265A KR810001047B1 (en) 1977-05-28 1977-05-28 Method for preparing cyclic acetal derivative of sterylglucoside

Publications (1)

Publication Number Publication Date
KR810001047B1 true KR810001047B1 (en) 1981-09-07

Family

ID=19204400

Family Applications (1)

Application Number Title Priority Date Filing Date
KR7701265A Expired KR810001047B1 (en) 1977-05-28 1977-05-28 Method for preparing cyclic acetal derivative of sterylglucoside

Country Status (1)

Country Link
KR (1) KR810001047B1 (en)

Similar Documents

Publication Publication Date Title
SU902666A3 (en) Method of preparing pleuromutiline glycoside derivatives
DE2750812C2 (en) 4-alkoxy-4-desmethoxydaunomycins and process for their preparation
IL25493A (en) Pregnano(17alpha,16alpha-d)oxazolines
KR810001047B1 (en) Method for preparing cyclic acetal derivative of sterylglucoside
DE3887212T2 (en) Process for the preparation of derivatives of 6,7-diazyl-7-deacetylforskolin.
US4257949A (en) Bisnoraldehyde-22-enamine process
KR900000266B1 (en) Method for preparing ethyl ester of apovincaminic acid
US4849512A (en) 3-acylamino-3-deoxyallose derivatives
JPS5831359B2 (en) Cyclic acetal derivative of steryl glucoside
US4174451A (en) 2-Furyl-(3,4-dimethyl-2-pyridyl)-carbinol
KR820001263B1 (en) Process of preparing for steryl gluco-side acetal derivatives
US3025309A (en) Delta2-androstene and etiocholene compounds and process for preparing same
KR800001451B1 (en) Process for the preparation of 1,3,5-trisubstitude benzene derivative
JPS5831358B2 (en) Acetal derivatives of steryl glucosides
KR820002232B1 (en) Triamcynolone acetonide esters and preparation thereof
JPS58116500A (en) Sterol derivative
US2881170A (en) Tropaminone compounds and a process of making same
JP2905931B2 (en) Process for producing optically active 2-cyclopentenones
JP2513222B2 (en) Novel pyrimidine derivative
SU455960A1 (en) Method for preparing 4-bromomethylthiazolin-2-one
KR790001684B1 (en) Process for the preparation of 5-benzyl picolinic acids
HU193454B (en) Process for producing 3-phenyl-butyraldehyde derivatives
US3102122A (en) Process of preparing griseofulvic acid
KR800001450B1 (en) Method for preparing 1, 3, 5-trisubstituted benzene derivative
US3264285A (en) Novel 19-nor-testosterone-17-hemiacetals and -hemiacetal esters

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19880908

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19880908

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000